Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Type of drug preparation | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Oral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Solid dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Has state of matter (attribute) | Solid (state of matter) | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Cephalexin 500mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely cefixime 200 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely cefprozil 250 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Cefprozil 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely tetracycline 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Compound tetracycline 300mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Doxycycline 100mg dispersible tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Minocycline 50mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Minocycline 100mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely oxytetracycline (as oxytetracycline dihydrate) 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Neomycin sulfate 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Erythromycin 250 mg gastro-resistant oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Erythromycin 500mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Erythromycin (as erythromycin stearate) 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Clarithromycin 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely clarithromycin 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Clarithromycin 500mg m/r tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely azithromycin dihydrate 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Spiramycin 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Colistin sulfate 1.5million units tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely sodium fusidate 250 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Co-trimoxazole 80mg/400mg dispersible tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Co-trimoxazole 160mg/800mg dispersible tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Co-trimoxazole 120mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sulfalene 2 g oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely sulfadiazine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sulfaguanidine 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely trimethoprim 100 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Trimethoprim 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely ethambutol hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ethambutol hydrochloride 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Isoniazid 50mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Isoniazid 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Pyrazinamide 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Rifampicin+isoniazid 150mg/100mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely dapsone 50 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Dapsone 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Metronidazole 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely metronidazole 400 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Metronidazole 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely tinidazole 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nitrofurantoin 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely nitrofurantoin 100 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Hexamine hippurate 1g tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely ciprofloxacin 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely ciprofloxacin 750 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely ciprofloxacin 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ofloxacin 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ofloxacin 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Norfloxacin 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely levofloxacin 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Levofloxacin 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Amphotericin 100mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Flucytosine 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Griseofulvin 125 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Griseofulvin 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ketoconazole 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nystatin 500,000units tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Terbinafine (as terbinafine hydrochloride) 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Aciclovir 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Aciclovir 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Acyclovir 800mg dispersible tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Acyclovir 200mg dispersible tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Aciclovir 400mg dispersible tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Aciclovir 800 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Inosine pranobex 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Famciclovir 250mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Famciclovir 125 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Famciclovir 750 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Famciclovir 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Didanosine 150 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Didanosine 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Didanosine 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely didanosine 200 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Zalcitabine 750 microgram oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Zalcitabine 375 microgram oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely valaciclovir (as valaciclovir hydrochloride) 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Lamivudine 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nevirapine 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nelfinavir 250mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Abacavir 300mg tablet (substance) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Chloroquine phosphate 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely primaquine 7.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Proguanil hydrochloride 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Pyrimethamine 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Quinine bisulfate 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Quinine dihydrochloride 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely quinine hydrochloride 300 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely quinine sulfate 200 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) |
Start Previous Page 9 of 28 Next End
This concept is not in any reference sets